- Home
- CADL vs NATH Comparison
CADL vs NATH Comparison
Compare CADL & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- NATH
- Stock Information
- Founded
- CADL 1999
- NATH 1916
- Country
- CADL United States
- NATH United States
- Employees
- CADL N/A
- NATH N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- CADL Health Care
- NATH Consumer Discretionary
- Exchange
- CADL Nasdaq
- NATH Nasdaq
- Market Cap
- CADL 306.4M
- NATH 330.5M
- IPO Year
- CADL 2021
- NATH N/A
- Fundamental
- Price
- CADL $11.63
- NATH $100.10
- Analyst Decision
- CADL Strong Buy
- NATH
- Analyst Count
- CADL 4
- NATH 0
- Target Price
- CADL $19.75
- NATH N/A
- AVG Volume (30 Days)
- CADL 1.2M
- NATH 14.2K
- Earning Date
- CADL 03-27-2025
- NATH 02-06-2025
- Dividend Yield
- CADL N/A
- NATH 1.95%
- EPS Growth
- CADL N/A
- NATH 24.88
- EPS
- CADL N/A
- NATH 5.80
- Revenue
- CADL N/A
- NATH $146,386,000.00
- Revenue This Year
- CADL N/A
- NATH N/A
- Revenue Next Year
- CADL N/A
- NATH N/A
- P/E Ratio
- CADL N/A
- NATH $17.27
- Revenue Growth
- CADL N/A
- NATH 6.83
- 52 Week Low
- CADL $1.34
- NATH $64.02
- 52 Week High
- CADL $14.60
- NATH $102.81
- Technical
- Relative Strength Index (RSI)
- CADL 72.95
- NATH 76.91
- Support Level
- CADL $8.11
- NATH $97.85
- Resistance Level
- CADL $13.68
- NATH $102.50
- Average True Range (ATR)
- CADL 0.78
- NATH 3.20
- MACD
- CADL 0.42
- NATH 1.64
- Stochastic Oscillator
- CADL 70.29
- NATH 87.68
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.